Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Gary Riordan, Kathy Surace-Smith, Michael Aicher

Premium

NanoString Technologies has appointed Gary Riordan as VP of quality and regulatory affairs and Kathy Surace-Smith as VP and general counsel.

Riordan formerly was VP of quality and regulatory affairs at Sequenom and director of regulatory affairs at Roche's Ventana Medical Systems.

Surace-Smith recently was VP and general counsel and corporate secretary of SonoSite, and she previously was VP and general counsel at Metawave Communications.


Ariosa Diagnostics has appointed Michael Aicher to its board of directors. He is currently the CEO of Omicia. Previously, he was co-founder and CEO of the National Genetics Institute, a wholly owned subsidiary of Laboratory Corporation of America.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.